-
Journal of Pain Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Comparison of the effects of dietary factors in the management and prophylaxis of migraine
Original Research
(3301) Views (998) Full article downloads
Authors: Beyazit Zencirci
Published Date July 2010
Volume 2010:3 Pages 125 - 130
DOI: http://dx.doi.org/10.2147/JPR.S9437
Beyazit Zencirci11Department of Anesthesiology and Reanimation, Medical Faculty of Sutcu Imam University, Kahramanmaras, Turkey
Abstract: Migraine is defined as a disorder characterized by intermittent headache episodes, accompanied with nausea, photophobia and/or phonophobia. Pharmacological therapy is in accordance with the severity of pain and may include acute, prophylactic and most commonly both approaches. The aim of the acute therapy is stopping or alleviating the attack or progression of the pain and in case of a migraine attack that has started, lessening the pain it. Preventive therapy aims to reduce attack frequency and severity. This study was designed to evaluate the effect of dietary factors in the management and prophylaxis of migraine in cases diagnosed as having migraine disorder according to the 2003-IHS criteria. Fifty consecutive Turkish patients (13 men, 37 women) with diagnosis of migraine were randomly divided into two groups for treatment protocols with the written approval of the ethics committee. The cases in the first group (K) were treated with metoprolol, vitamin B2 (riboflavin), and naproxen sodium just at the aura or at the beginning of the attacks. The cases in the second group (D) were also supplied with a comprehensive dietary list arranged by our algology clinics in addition to the same medication protocol. There were no demographic differences between the cases (P > 0.05). VAS scores were lower in group D than group K (P < 0.01), and also the migraine attack frequencies and monthly amounts of analgesic consumed amounts were also statistically significantly less. It was concluded that beta-blocker and riboflavin therapy supplemented with convenient diet with appropriate alternatives in patients with migraine disorder was associated with statistically significant decreases in headache frequency, intensity, duration and medication intake.
Keywords: migraine, food intake, trigger
Other articles by Dr Beyazit Zencirci
Marfan syndrome with acute abdomen: a case report
Postdural puncture headache and pregabalin
Safe spinal anesthesia in a woman with chronic renal failure and placenta previa
Sertraline-induced pseudocholinesterase enzyme deficiency
Readers of this article also read:
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Postdural puncture headache and pregabalin
Safe spinal anesthesia in a woman with chronic renal failure and placenta previa
Pregabalin for the management of fibromyalgia syndrome
New and emerging therapeutic agents for the treatment of fibromyalgia: an update
Pillow use: the behavior of cervical stiffness, headache and scapular/arm pain
Analgesic efficacy of oral gabapentin added to standard epidural corticosteroids in patients with failed back surgery
Sertraline-induced pseudocholinesterase enzyme deficiency
Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- An eight-week yoga intervention is associated with improvements in pain, psychological functioning and mindfulness, and changes in cortisol levels in women with fibromyalgia
- Problems and barriers of pain management in the emergency department: Are we ever going to get better?
- A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
- Anesthesiologists’ perception of patients’ anxiety under regional anesthesia




